Noviogendix Holding

Noviogendix Holding

Provider of molecular diagnostics and services to physicians, clinics, and hospitals to personalize the diagnosis and treatment of cancer.

  • Edit
Get premium to view all results
DateInvestorsAmountRound
investor

€0.0

round

$8.8m

Valuation: $8.8m

Acquisition
Total Funding000k
Notes (0)
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads